After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price upped by Wells Fargo & Company from $120.00 to $140.00 ...
As the U.S. market grapples with the impact of newly imposed tariffs and a broad-based sell-off, investors are keenly ...
Gilead Sciences (NASDAQ:GILD – Free Report) had its price target raised by Oppenheimer from $115.00 to $132.00 in a report ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results